What are the recommendations for managing patients with cross-reactivity to one type of iron infusion?
The evidence shows that managing cross-reactivity to iron infusions involves immediate cessation of any reaction-inducing infusion, consideration of an alternative iron formulation, and prepared management of hypersensitivity reactions, particularly anaphylaxis, with close patient monitoring.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24336627
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00